The AI newswire
Companies to Jointly Invest up to $1 Billion Over Five Years in Infrastructure and Research News Summary: SAN FRANCISCO, Calif. — J.P. Morgan Healthcare Conference — January 12, 2026 —…
News Summary: SAN FRANCISCO, Calif. — J.P. Morgan Healthcare Conference — January 12, 2026 — NVIDIA today announced a major expansion of NVIDIA BioNeMo™, an open development platform that enables…
U.S. Secretary of Energy Chris Wright launched a new chapter to secure American leadership in autonomous biological discovery yesterday alongside scientists and private partners at Pacific Northwest National Laboratory. RICHLAND,…
Our global hackathon on protein folding has set a new benchmark for open-source AI-driven innovation in drug development. DARMSTADT, Germany — October 24, 2025 — Merck KGaA, Darmstadt, Germany, a…
Leading Global Pharma Joins Danish Enterprises, Startups and Public Health Systems Using AI Factories to Improve Drug Discovery and Healthcare PARIS, France — GTC Paris at VivaTech — June 11,…
Leading Global Pharma Joins Danish Enterprises, Startups and Public Health Systems Using AI Factories to Improve Drug Discovery and Healthcare PARIS, France — GTC Paris at VivaTech — June 11,…
NEWTON, Mass. — March 26, 2025 — GV20 Therapeutics (GV20), a clinical-stage AI-powered biotherapeutics company, has entered into a strategic research collaboration with Mitsubishi Tanabe Pharma Corporation (MTPC). Under this…
Pheno.AI’s Human Phenotype Project (HPP) to Catalyze the Future of AI-Driven Health with Japanese Cohort TOKYO, Japan — March 26, 2025 — Corundum Systems Biology Inc. (CSB), a leading investment…
RESTON, Va. — March 26, 2025 — Cyberhill Partners, in partnership with data.world and KUNGFU.AI, has been awarded a contract with the Defense Innovation Unit (DIU) to develop a modernized…
TAIPEI, Taiwan — March 26, 2025 — AnHorn Medicines, a pioneering AI-driven new drug discovery company, is pleased to announce that, AH-001, a first-in-class protein degrader for androgenetic alopecia (AGA),…